While opposing evidence for the role of TREM-2 in AD still need to be fully reconciled, context-dependent variations in TREM2 effects may have significant clinical implications for potential AD treatments that selectively target TREM-2. This evidence concerns the gene TREM2 and Alzheimer disease.